<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
	<url>
		<loc>https://tradingonline.com/news/hims-hers-farmaci-dimagranti-55961/</loc>
		<news:news>
			<news:publication>
				<news:name>TradingOnline.com</news:name>
				<news:language>it</news:language>
			</news:publication>
			<news:publication_date>2026-11-10T13:28:20+00:00</news:publication_date>
			<news:title>Hims &amp; Hers, ricavi +49% ma -14% in Borsa: l&#8217;avviso a chi punta sui farmaci dimagranti</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://tradingonline.com/news/softbank-perdita-rimbalzo-ai-55954/</loc>
		<news:news>
			<news:publication>
				<news:name>TradingOnline.com</news:name>
				<news:language>it</news:language>
			</news:publication>
			<news:publication_date>2026-11-10T07:16:47+00:00</news:publication_date>
			<news:title>SoftBank perde 7 miliardi e vola +13,9%: il paradosso AI nascosto nel tuo ETF tech</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://tradingonline.com/news/meta-jpmorgan-pubblicita-ai-55951/</loc>
		<news:news>
			<news:publication>
				<news:name>TradingOnline.com</news:name>
				<news:language>it</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T17:23:13+00:00</news:publication_date>
			<news:title>Meta +5%, JPMorgan la preferisce a Google: la pubblicità AI inizia a pagare nel tuo ETF</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://tradingonline.com/news/nvidia-huang-indagine-board-55932/</loc>
		<news:news>
			<news:publication>
				<news:name>TradingOnline.com</news:name>
				<news:language>it</news:language>
			</news:publication>
			<news:publication_date>2026-11-09T07:59:07+00:00</news:publication_date>
			<news:title>Nvidia, il board indaga su Huang, titolo fino a -3%: il nodo adesso è la governance</news:title>
		</news:news>
	</url>
</urlset>